ERBB2 and glioblastoma: As expected CD4+ EphA3 CAR T cells co-cultured with GBM U251CL target cells for 18 hours exhibited antigen-specific activation as measured by the cell surface upregulation of CD137 similar to the HER2 CAR (figure 2C).